GLP-1 Cancer Risk: What New 2026 Studies Suggest About Peptide Medicine
GLP-1 cancer risk is suddenly a mainstream question. Alex Keane explains what the newest studies suggest, what they do not prove, and why peptide biology matters.
June 16, 20268 min read
Read Article ›